Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans

Detalhes bibliográficos
Autor(a) principal: Routh,Madhushree M
Data de Publicação: 2013
Outros Autores: Chauhan,Nitin M, Karuppayil,S Mohan
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Microbiology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822013000300029
Resumo: Candida infections are very common in cancer patients and it is a common practice to prescribe antifungal antibiotics along with anticancer drugs. Yeast to hyphal form switching is considered to be important in invasive candidiasis. Targeting morphogenetic switching may be useful against invasive candidiasis. In this study, we report the antimorphogenetic properties of thirty cancer drugs.
id SBM-1_8af74b0500586aba30fe7d47694cd8f5
oai_identifier_str oai:scielo:S1517-83822013000300029
network_acronym_str SBM-1
network_name_str Brazilian Journal of Microbiology
repository_id_str
spelling Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicansCandida albicansmorphogenetic switchingcancer drugsantifungal antibioticsCandida infections are very common in cancer patients and it is a common practice to prescribe antifungal antibiotics along with anticancer drugs. Yeast to hyphal form switching is considered to be important in invasive candidiasis. Targeting morphogenetic switching may be useful against invasive candidiasis. In this study, we report the antimorphogenetic properties of thirty cancer drugs.Sociedade Brasileira de Microbiologia2013-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822013000300029Brazilian Journal of Microbiology v.44 n.3 2013reponame:Brazilian Journal of Microbiologyinstname:Sociedade Brasileira de Microbiologia (SBM)instacron:SBM10.1590/S1517-83822013000300029info:eu-repo/semantics/openAccessRouth,Madhushree MChauhan,Nitin MKaruppayil,S Mohaneng2014-02-03T00:00:00Zoai:scielo:S1517-83822013000300029Revistahttps://www.scielo.br/j/bjm/ONGhttps://old.scielo.br/oai/scielo-oai.phpbjm@sbmicrobiologia.org.br||mbmartin@usp.br1678-44051517-8382opendoar:2014-02-03T00:00Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)false
dc.title.none.fl_str_mv Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
title Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
spellingShingle Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
Routh,Madhushree M
Candida albicans
morphogenetic switching
cancer drugs
antifungal antibiotics
title_short Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
title_full Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
title_fullStr Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
title_full_unstemmed Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
title_sort Cancer drugs inhibit morphogenesis in the human fungal pathogen, Candida albicans
author Routh,Madhushree M
author_facet Routh,Madhushree M
Chauhan,Nitin M
Karuppayil,S Mohan
author_role author
author2 Chauhan,Nitin M
Karuppayil,S Mohan
author2_role author
author
dc.contributor.author.fl_str_mv Routh,Madhushree M
Chauhan,Nitin M
Karuppayil,S Mohan
dc.subject.por.fl_str_mv Candida albicans
morphogenetic switching
cancer drugs
antifungal antibiotics
topic Candida albicans
morphogenetic switching
cancer drugs
antifungal antibiotics
description Candida infections are very common in cancer patients and it is a common practice to prescribe antifungal antibiotics along with anticancer drugs. Yeast to hyphal form switching is considered to be important in invasive candidiasis. Targeting morphogenetic switching may be useful against invasive candidiasis. In this study, we report the antimorphogenetic properties of thirty cancer drugs.
publishDate 2013
dc.date.none.fl_str_mv 2013-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822013000300029
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822013000300029
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1517-83822013000300029
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Microbiologia
publisher.none.fl_str_mv Sociedade Brasileira de Microbiologia
dc.source.none.fl_str_mv Brazilian Journal of Microbiology v.44 n.3 2013
reponame:Brazilian Journal of Microbiology
instname:Sociedade Brasileira de Microbiologia (SBM)
instacron:SBM
instname_str Sociedade Brasileira de Microbiologia (SBM)
instacron_str SBM
institution SBM
reponame_str Brazilian Journal of Microbiology
collection Brazilian Journal of Microbiology
repository.name.fl_str_mv Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)
repository.mail.fl_str_mv bjm@sbmicrobiologia.org.br||mbmartin@usp.br
_version_ 1752122205584490496

Registros relacionados